Actively Recruiting
Impact of Donor HIV Status on Opportunistic Infections, Cancer, and Outcomes in HIV-Positive Liver Transplant Recipients
Led by Johns Hopkins University · Updated on 2026-09-09
80
Participants Needed
19
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how receiving liver transplants from donors with HIV compares to receiving livers from donors without HIV in people who have HIV. The goal is to better understand the risks of opportunistic infections and cancer after transplant in these patients. This research builds on changes from the 2013 HIV Organ Policy Equity HOPE Act, which allowed people with HIV to receive organs from HIV-positive donors as part of research. Participants will receive liver transplants from either deceased donors with HIV or without HIV. The study monitors these groups over time to compare outcomes. The study tracks events from the time of transplant through at least 6 months, up to 4 years post-transplant, including infections, cancer, survival, graft function, and transplant complications. During the study, participants will be followed closely with assessments of infections, cancer, HIV control, graft survival, and adverse events. Researchers will measure the incidence of opportunistic infections or cancer and other health outcomes after transplant. The study lasts up to 4 years after transplant for each participant, with ongoing monitoring to gather comprehensive data on long-term health outcomes.
CONDITIONS
Brief Title
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)
Research Team
C
Christine Durand, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here